title: Clinical and immunological features of the HIV infection associated with chronic hypertrophic parotitis in children.
abstract: The study refers to children of 0-15 years of age, infected with HIV and who developed a chronic hypertrophic parotitis (CHP), admitted to the "Colentina" Clinic of Infectious Diseases--Paediatrics in Bucharest, between January 1, 1990 and May 15, 1993. Among the total number of 579 HIV infection cases hospitalized in the above-mentioned period, 135 were associated with CHP, hence an incidence of 23.3%. The HIV infection was defined by two ELISA-positive assays, confirmed by a Western-blot test. No specific laboratory test for the diagnosis of CHP in the course of HIV infection was available. The detection of a uni- or bilateral painless parotid enlargement, without signs of skin inflammation in HIV-infected children, was conclusive for the diagnosis of CHP. IgG type anticytomegalovirus antibodies were detected in 41.17% (7/17) and anti-Toxoplasma antibodies in 50% of the tested cases (4/8). The immunogram performed in 85 children showed increased IgG values in 92.94% of cases (79/85) and increased IgM values in 85.88% (73/85). There was recorded a significant increase in the levels of immunoglobulins, especially of IgM, which exceeded 13 times the normal values. The CD8 cells were frequently normal or increased (94.44%, respectively 34/36). CHP appeared before a marked deterioration of CD4 cells, simultaneously with the CD8 cells proliferation. CHP developed at a stage of the HIV infection when the medium-term prognosis was still considered favourable.
authors.affiliation: Colentina Clinic of Infectious Diseases-Paediatrics Bucharest, Romania.
authors.forename: L
authors.initials: L
authors.lastname: Madelena
authors.forename: I
authors.initials: I
authors.lastname: Drăgan
authors.forename: M
authors.initials: M
authors.lastname: Mihordea
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D006984:Hypertrophy; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010309:Parotitis / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D011502:Protein-Energy Malnutrition / Q000453:epidemiology; D012016:Reference Values
chemical_list: D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M